Certolizumab pegol to prevent adverse pregnancy outcomes in patients with antiphospholipid syndrome and lupus anticoagulant (IMPACT): results of a prospective, single-arm, open-label, phase 2 trial

D. Ware Branch, Mimi Kim, Marta Guerra, Joseph Worden, Carl A. Laskin, Maria T. DeSancho, Inna Landres, Jason S. Knight, Haley S Slosberg, Margaret Minett, Jane E. Salmon